Connect with us


Ivermectin – Truth & Totalitarianism

Ivermectin – Truth & Totalitarianism

Authored by Justus R. Hope via,

Calling out the lie

"Merck stock surged 10% Friday after it said its investigational pill cuts the risk of hospitalization and death in COVID-19.



Ivermectin - Truth & Totalitarianism

Authored by Justus R. Hope via,

Calling out the lie

"Merck stock surged 10% Friday after it said its investigational pill cuts the risk of hospitalization and death in COVID-19 patients...The pill reduced the risk of hospitalization or death by about 50%,” Merck and its partner, Ridgeback Biotherapeutics, said in a statement Friday.

"This is a phenomenal result. This is a profound game-changer to have an oral pill that had this kind of effect, this magnitude of effect in patients who are at high risk who are already symptomatic," former FDA Commissioner Scott Gottlieb said Friday on CNBC about results of the interim analysis.

"Meanwhile, shares of COVID vaccine makers Pfizer and Moderna fell 2.5% and 10%, respectively."

This puts Dr. Scott Gottlieb between a rock and a hard place.

On the one hand, as a member of Pfizer's Board of Directors, he is paid handsomely to attend a few board meetings per year, yet on the other hand, he must not be too glowing in his praise of the antiviral, which might lead people away from the Pfizer vaccine. Moreover, it could affect sales just as it has already dropped the stock price.

In 2020, Gottlieb was paid $338,587 by Pfizer. In 2020, he also earned $525,850 as a director of Illumina. Due to his former FDA Chief status, Gottlieb is in high demand as one word of favor from him can send a stock price soaring.

He has served on multiple other boards, including Tempus Labs, National Resilience, and the Mount Sinai Health System. It must be a daunting task to walk the line by promoting one corporate interest while not offending any of the others.

But the good news is that soon, Pfizer, too, will be peddling their antiviral drug, which should make up for any drop in their vaccine sales.

"Pfizer is testing whether its pill—PF-07321332—can prevent infection in people exposed to the virus or benefit patients who have not been hospitalized with COVID-19."

Roche and Atea are not far behind with their antiviral pills, and soon all of Big Pharma can get in on the action. They have timed it perfectly.

While shutting down any competition from repurposed drugs like HCQ or Ivermectin, they deftly rolled out the vaccines first, making sure not to confuse the consumer with antiviral pills that would only be allowed AFTER the majority of the population had been vaccinated. 

The one glitch is that Merck's Molnupiravir only surfaced AFTER a prominent scandal involving Merck lying three times.

Just as Peter would disown Christ three times before the cry of the rooster, Merck would turn their back on their creation with three lies about Ivermectin before they would accept the payoff from the United States government.

On February 4, 2021, Merck, the corporation behind the monumental Mectizan Program, which rescued the world from River Blindness, told three untruths about Ivermectin.

Lie #1: No scientific basis for a potential therapeutic effect against COVID-19 from preclinical studies;


Lie #2: No meaningful evidence for clinical activity or clinical efficacy in patients with COVID-19 disease.


Lie #3: A concerning lack of safety data in the majority of studies.


However, the Monash preclinical study disproved the first statement showing a massive 99.98% reduction in viral load with a single Ivermectin treatment in cell culture.

The second statement is disproved by the FLCCC's Public Statement issued January 18, 2021, that reports colossal evidence for Ivermectin's clinical activity and efficacy against COVID-19 in clinical settings:

a. Large reductions in mortality rates;

b. Shorter durations of hospital stay;

c. Profound reductions in the infectivity rate in both pre- and post-exposure prophylaxis studies;

d. Faster times to clinical recovery;

e. Faster times to viral clearance.

Finally, the third statement concerning "lack of safety data" contradicts the published WHO safety data. In 3.7 billion doses of Ivermectin given over four decades, Ivermectin has proven exceedingly safe.

Moreover, more than anyone, Merck is in the position to know Ivermectin’s true safety profile as they provided those billions of doses for the Mectizan Donation program.

However, lying was required, and the payoff came on Wednesday, June 9, 2021, when Merck got a fat reward. They announced the US government had agreed to pay $1.2 billion for 1.7 million doses of their new antiviral, Molnupiravir, BEFORE clinical testing showed either effectiveness or safety. Our hard-earned tax dollars were irresponsibly handed over to Merck by an agency charged with a fiduciary duty to protect our health.

So in the end, Scott Gottlieb did not endanger Pfizer's bottom line. Just as Moderna was choreographed to go first in the vaccine rollout, Merck was first with the antiviral, and Pfizer first with the booster. They would take turns as there was more than enough profit to go around. Soon it would be Pfizer’s turn at the antiviral trough, but they had to be patient for now. There was an order and method to this.

But the craftiest strategy of all was Merck's: Accuse the other side of that which you are guilty.

This quote has been variously attributed to Karl Marx, Vladimir Lenin, and Joseph Goebbels, the Nazi propaganda minister. Regardless of its source, it has proven remarkably effective as a propaganda tactic throughout modern history, and Merck was betting on this to sell the public on Molnupirivar. However, the move backfired. In the case of Ivermectin, they falsely argued that it was ineffective and unsafe while their own drug suffered from both.

For example, one could argue, "There is a concerning lack of safety data" regarding Molnupirivar. Indeed, it does not have decades of safety data like Ivermectin; it does not even have years. The little safety data pertains to a dearth of Phase II and Phase III clinical trials, which total less than a few thousand patients.

While Ivermectin's safety data with over 40 years of treatment in over 3.7 billion doses is truly robust, Molnupiravir's safety numbers are barely rudimentary. In short, Molnupiravir's safety data is concerning because of its lack. 

Of more concern is a recent study showing the alarming potential of Molnupiravir’s metabolite, NHC, to induce mutations. In a peer-reviewed study published in the Journal of Biological Chemistry, the author writes, “The mutagenic effect of NHC has been shown in animal cell cultures, raising concerns on the potential risk of molnupiravir-induced tumorigenesis and the emergence of detrimental mutations in sperm precursor cell generation and embryo development.”

I don’t know about you, but that would be enough for most of my patients to decide against this drug. With all due respect to Dr. Gottlieb, if the choice were between a drug with a 40-year safety profile of excellence versus a new experimental one that could introduce mutations into germ cells, it would be a no brainer.

As if this were not enough, another group of researchers at the Lineberger Comprehensive Cancer Center associated with the University of North Carolina at Chapel Hill are also concerned. 

They write, “The concern would be that mutations in host DNA could contribute to the development of cancer or cause birth defects either in a developing fetus of through incorporation into sperm precursor cells.” 

This may be the best time to mention that cheap, repurposed drugs, all FDA approved as safe for other conditions, are one of the best ways to address terminal cancers. They have well-defined and often long-term safety profiles, and cocktails of such old drugs hold great promise as adjuncts in cancer prevention and treatment. Moreover, unlike experimental new medicines with little safety testing, repurposed drugs will not give you cancer.

As for meaningful clinical activity or efficacy in patients with COVID-19, there are also concerns with Molnupiravir. The hospital trials were stopped early. Where is the data for inpatients? Where is the data for patients on ventilators? Where is the evidence for pre-exposure prophylaxis? 

The limited trials that have been performed only suggest a correlation between Molnupiravir use and a lower rate of hospitalization and fewer deaths based on low numbers of patients. But the evidence is lacking on safety, prevention of disease, and treatment of late disease. This is where the evidence on Ivermectin is overwhelming.

However, the evidence of effectiveness for Molnupiravir is sketchy at best.

Moreover, on the use of Molnupiravir in mild and moderate disease, we have one study - only partially completed - showing 7.3% death OR hospitalization in the drug group versus 14.1% of those receiving placebo. The fact that deaths were combined with hospitalizations does not mean that 48% fewer in the treatment group died. It means the sum of deaths and hospitalizations was 48% lower in the treatment group.

Moreover, the study only involved 775 patients. This is far too few on which to base an approval. Right? Isn't that what we have been told regarding Ivermectin? After all, we now have over 32 randomized controlled trials of Ivermectin in COVID, reflecting a 58% improvement in the Ivermectin groups compared to placebo. Thus, we have 65 clinical trials in total involving 655 scientists and 47,717 patients. We have been told this is insufficient evidence, so the Merck data on 775 patients cannot possibly be enough if we use the same standard.

With Ivermectin, we see an average of 86% improvement in 14 prophylaxis studies, a 66% improvement in 29 early treatment trials, a 40% improvement in 22 late treatment trials, a 57% improvement in the 26 mortality trials. This data has been updated to October 1, 2021. 

So, even assuming Molnupiravir effectively reduces death PLUS hospitalization by 48%, we still do not know how reliable this figure will be when looking only at death. Ivermectin's reduction in death in mild to moderate COVID-19 surpasses this number. 

Assuming more studies confirm Molnupiravir's lesser effect at reducing mortality in mild to moderate disease, we are still left with uncomfortable questions about its safety. However, Ivermectin's excellent long term safety profile is solid, and this alone will lead many to choose Ivermectin OVER Molnupirivar, especially when factoring in the possibilities of mutagenesis and gene toxicity.

The price of around $700 per course of treatment which involves ten pills, makes it vastly more expensive than Ivermectin, which might be fine if it were considerably more effective. But it isn’t, it is less effective, and it is potentially MUCH more dangerous. The fact the choice is being "forced" does not make it more appealing.

Perhaps the most distasteful dimension is that the drug was developed through deceit and propaganda under Merck's scandal with Ivermectin.  

It is part of an overall mandated program that robs people of their God-given liberty to choose their own medical treatment. 

The mandates have been fraught with division among leading scientists, including Dr. Robert Malone. Dr. Robert Malone discovered in-vitro and in-vivo RNA transfection and invented mRNA vaccines while he was at the Salk Institute in 1988. He helped draft "The Physicians Declaration," which was announced at the Global COVID Summit held in Rome, Italy.

The Physician's Declaration is not unlike the US Declaration of Independence, as both documents enumerate a series of injustices that create the need for a Declaration.

In the case of the US Declaration of Independence, those injustices included taxation without representation, not providing fair hearings or trials - the lack of due process - and "exciting domestic insurrections amongst us." 

In the case of the Rome Physician's Declaration, these injustices include public policymakers who have forced a "one size fits all treatment strategy" to the Pandemic resulting in "needless illness and death." In addition, physicians have been subject to censorship of ideas, barriers from pharmacies, threats of censure, and loss of license for upholding their Hippocratic Oath to do no harm.

Censorship of  Senate testimony of Harvard and Yale-educated physicians by YouTube at the behest of government agencies should not be tolerated in a democratic society.

When the WHO and CDC degenerate into captured agencies that no longer serve the medical interests of the people, something needs to change.

The United States declared itself free from oppression from England in 1776 with the signing of the Declaration of Independence.

As of today’s date, some 10,000 physicians and health scientists have also signed the modern Physician Declaration and accused the public health agencies of "crimes against humanity."

Physicians have declared through this document that they "must be free to practice the art and science of medicine without fear of retribution, censorship, slander, or disciplinary action" and that physicians shall not be restricted from prescribing safe and effective treatments.  A fully informed patient should have the right to choose or decline medical treatment. This absolute right MUST be restored.

Taking a stand for truth is what is essential now. Over the last 18 months, Americans, indeed citizens of the developed world spanning from the United Kingdom to Australia, have been fed a steady diet of propaganda by  Big Pharma and Big Regulators being aided and abetted by complicit governments, media, and Big Tech.

These corrupt organizers seem to be driven by a desire for money, power, and control. Most citizens are either willing participants or are those who feel powerless to object. Most physicians who are part of organized medicine dare not speak out for fear of consequences. The NIH influences most of the world’s medical research through the strategic use of its nearly $50 billion annual budget. As a result, it can affect most medical societies, medical journals, most research, and thus it can and does control the way data is analyzed. 

The top medical journals have even published fraudulent studies to discredit unprofitable repurposed drugs.

These same medical journals have appointed questionable figures to investigate the origins of COVID-19, those with ties to coverups, and those who are likely to maintain the coverup.

From the AMA to the FDA to the New England Journal to the Lancet, the NIH controls organized medicine around the globe. But it cannot do so alone, especially abroad, which is why the WHO also figures prominently.

The WHO budget is about 10% of the NIH at $5.8 billion. 

The Gates Foundation contributes roughly 10% of the WHO budget. Thus both Dr. Anthony Fauci, director of the NIAID – an arm of the NIH, and Bill Gates, vaccine proponent of the world, play significant roles.

All those physicians who signed Dr. Malone’s Physician Declaration are genuinely courageous, just as were Thomas Jefferson, Ben Franklin, and John Hancock, those men of courage who signed the US Declaration of Independence. 

And, whether or not most recognize it, we, the citizens of the United States, those of Australia, and the United Kingdom, are living in an increasingly totalitarian world, run by Big Pharma, Big Regulators, and Big Tech where the politicians and governments are secondary.

This concept is very similar to the “soft totalitarianism” described in the book Live Not by Lies by Rod Dreher. In a thoughtful review, Abe Greenwald notes, “Lies are the lifeblood of totalitarianism; to resist, therefore, is to hold fast to the truth.”

Our world’s current soft totalitarianism goes unrecognized by most because it is so different in appearance from that of the Soviet Union, yet it is every bit as deadly. In quoting Dreher, totalitarian society is defined by, “An ideology (that) seeks to displace all prior traditions and institutions with the goal of bringing all aspects of society under control of that ideology…A totalitarian state is one that aspires to nothing less than defining and controlling reality.” 

In this Pandemic, those who do not conform to lockdowns, mask wear, or vaccination protocols are vilified, regardless of the science. As Greenwald observes, our totalitarianism is couched in the guise of “helping and healing others.” We live in a totalitarian “therapeutic culture.” Those who do not conform are branded as “the enemy (of the state).”

Dreher writes, “It masks its hatred of dissenters from its utopian ideology of helping and healing…In therapeutic culture, which has everywhere triumphed, the great sin is to stand in the way of the freedom of others to find happiness as they wish.”

As Aleksandr Solzhenitsyn often said, the antidote to totalitarianism has always been exposing the truth and then living in truth. It is what is essential now. Just as evil hates the light, lies hate the truth.  

Dreher correctly observes that living in truth requires courage to stand up for what is right. For example, he offers this quote from a Slovakian dissident:

 “The question is, which is going to win: fear or courage?” he says. “In the beginning, it was mostly a matter of fear. But once you started experiencing freedom—and you felt it, you felt freedom through the things you did— your courage grew. We experienced all this together. We helped one another to gradually build up the courage to do bigger things, like join the Candle Demonstration.” 

Fear is now falling while courage is rising. The word is slowly getting out through alternative media. Doctors are organizing resistance groups. Whereas six months ago, few patients had heard about Ivermectin, today most know about it, and many take it. 

There is a reason that so many health care professionals are speaking out against the mandates, and it may have something to do with the fact healthcare is their field. For example, if airline pilots, experts in their field, refused to fly on a specific model of 747 aircraft, would an average person wish to know why, or would they blindly jump on that plane – because the FAA declared it safe? Help get the truth out.

To patients everywhere, to all those whose voices have been silenced during this Pandemic, I advise the courage to live in the truth, share this message with others, and never yield to fear by remaining silent. Please share this article with your physician(s), share the link below, and ask them to sign the Physician’s Declaration. We are at 10,000 signatures now. When I started a petition on this spring, it was taken down by the censors. However, this declaration cannot be taken down.

Let us reach at least a million signatures. Then, when the signature box is opened for signing by the general public, please sign as well.

I now invite all physicians and medical scientists to join in truth with Dr. Malone, Dr. Fareed, Dr. McCullough, Dr. Tyson, and Dr. Kory and sign the Rome Physician’s Declaration here. Let us stand for truth, freedom, and Human Rights, which shall always prevail over totalitarianism. Let us honor our sacred Hippocratic Oath.

Tyler Durden Thu, 10/07/2021 - 00:10

Read More

Continue Reading

Spread & Containment

TV Show Mysteriously Deletes Poll After Vast Majority Oppose Mandatory Vaccination

TV Show Mysteriously Deletes Poll After Vast Majority Oppose Mandatory Vaccination

Authored by Paul Joseph Watson via Summit News,

A major morning television show in the UK deleted a Twitter poll asking if vaccines should be made mandatory..



TV Show Mysteriously Deletes Poll After Vast Majority Oppose Mandatory Vaccination

Authored by Paul Joseph Watson via Summit News,

A major morning television show in the UK deleted a Twitter poll asking if vaccines should be made mandatory after the results showed that 89% of respondents oppose compulsory shots.

Yes, really.

Good Morning Britain, which often tries to set the news agenda, posted the poll which asked the public, “With Omicron cases doubling every two days, is it time to make vaccines mandatory?”

The last screenshots Twitter users were able to obtain before the poll was wiped showed 89% oppose mandatory vaccinations, with just 11% in favor after a total of over 42,000 votes.

People demanded to know why the poll had been pulled, although it wasn’t exactly hard to guess.

Why did you delete this poll, is it because you were asked? Or because it shows the people don’t support this s**t, this tyrannical future your colleagues seem to want. We see you,” commented one respondent.

“Guess that wasn’t the answer they were looking for,” remarked another.

Good Morning Britain has failed to explain why it removed the poll.

However, it’s unsurprising given that the broadcast has been a vehicle for pushing pro-lockdown messaging since the start of the pandemic.

For most of that time, it was hosted by Piers Morgan, an aggressive proponent of lockdowns, mandatory vaccines and face masks.

The show also regularly features Dr. Hillary Jones, someone who at the start of the pandemic warned that face masks could make the spread of the virus worse, before getting the memo and doing a complete 180.

*  *  *

Brand new merch now available! Get it at

In the age of mass Silicon Valley censorship It is crucial that we stay in touch. I need you to sign up for my free newsletter here. Support my sponsor – Turbo Force – a supercharged boost of clean energy without the comedown. Get early access, exclusive content and behinds the scenes stuff by following me on Locals.

Tyler Durden Thu, 12/09/2021 - 03:30

Read More

Continue Reading


Life Sciences Expansions Take Off as 2021 Wraps Up

Several life sciences companies and life science-focused real estate firms announced expansion plans as 2021 comes to an end.



Life Sciences Expansions Take Off as 2021 Wraps Up

Several life sciences companies and life science-focused real estate firms have announced expansion plans as 2021 comes to an end. Here’s a look.

Novavax to Expand Maryland Campus

Novavax, on the cusp of getting its COVID-19 vaccine authorized in numerous countries around the world, is expanding its footprint in Gaithersburg, Md., where it is headquartered. The European Medicines Agency (EMA) is expected to authorize the company’s vaccine soon, and so is the U.S. Food and Drug Administration (FDA). Czechia has already ordered 370,000 doses, with deliveries expected at the beginning of 2022. The company also has a deal with Fujifilm Diosynth Biotechnologies to manufacture millions of doses of the Novavax vaccines at its facilities in Billingham, U.K., with a £400 million investment in expansion.

Four Corners Acquired 150,000-Square-Foot Complex in Belmont, Calif.

Four Corners Properties acquired a 150,000-square-foot office building in Belmont, Calif., called the Shoreway Innovation Center. The seller was Westlake Group. Westlake bought it in 2016 for $61 million. The company plans to expand its use for life sciences, noting that 82% of it is currently leased to a mix of tenants with an average of less than three years lease term remaining.

“Shoreway Innovation Center offers the opportunity to bring office and life sciences space to a market where tenant demand is far outpacing available supply,” said Mike Taquino, executive vice president of CBRE’s Northern California Capital Markets team.

Genentech Leases Building Under Construction in South San Francisco

Source: BioSpace

Boston Properties and Alexandria Real Estate Equities are leasing a building under construction in South San Francisco to Genentech. It will be the first phase of a life sciences campus. The building is at 751 Gateway and is 229,000 square feet. The campus will be called Gateway Commons and is a joint venture between the two real estate firms. They expect initial occupancy toward the end of 2024. Genentech has been headquartered in South San Francisco for forty years, with a large corporate headquarters made up of 4.7 million square feet of five neighborhood hubs. The new site is about one mile’s distance from their main campus.

Mispro Biotech to Open New Facility in North Carolina in Early 2022

Mispro Biotech Services plans to open a new facility in Research Triangle Park (RTP), N.C., in early 2022. Mispro is a leading contract vivarium organization (CVO). The new facility, a full-service vivarium research facility, will be central to one of RTP’s biopark campuses.

“Since we first opened our doors here in 2013, we have seen incredible growth in the RTP cluster,” said Philippe Lamarre, chief executive officer of Mispro. “The time was right to expand into a new facility with more space and modern amenities where we can support the influx of biotechs who are seeking in vivo lab space.”

Laura Gunter, president of NCBIO, representing the life sciences industry in North Carolina, noted, “Mispro has become a cornerstone of the Triangle ecosystem as contract research and support companies are finding increased favor. Biotechs of all sizes and therapeutic disciplines are focusing more on their core competencies, which is opening the door to innovation like Mispro’s contract vivarium option. We are pleased to see their decision to expand here and support more North Carolina companies.”

BioSpace source:

Read More

Continue Reading


Over 170 companies delisted from major U.S. stock exchanges in 12 months

  Over the years, United States-based exchanges have remained an attractive destination for most companies aiming to go public. With businesses jostling to join the trading platforms, the exchanges have also delisted a significant number of companies….





Over the years, United States-based exchanges have remained an attractive destination for most companies aiming to go public. With businesses jostling to join the trading platforms, the exchanges have also delisted a significant number of companies.

According to data acquired by Finbold, a total of 179 companies have been delisted from the major United States exchanges between 2020 and 2021. In 2021, the number of companies on Nasdaq and the New York Stock Exchange (NYSE) stands at 6,000, dropping 2.89% from last year’s figure of 6,179. In 2019, the listed companies stood at 5,454.

NYSE recorded the highest delisting with companies on the platform, dropping 15.28% year-over-year from 2,873 to 2,434. Elsewhere, Nasdaq listed companies grew 7.86% from 3,306 to 3,566. Data on the number of listed companies on NASDAQ and NYSE is provided by The World Federation of Exchanges.

The delisting of the companies is potentially guided by basic factors such as violating listing regulations and failing to meet minimum financial standards like the inability to maintain a minimum share price, financial ratios, and sales levels. Additionally, some companies might opt for voluntary delisting motivated by the desire to trade on other exchanges.

Furthermore, the delisting on U.S. major exchanges might be due to the emergence of new alternative markets, especially in Asia. China and Hong Kong markets have become more appealing, with regulators making local listings more attractive. Over the years, exchanges in the region have strived to emerge as key players amid dominance by U.S. equity markets. As per a previous report, the U.S. controls 56% of the global stock market value.

A significant portion of the delisted companies also stems from the regulatory perspective pitting U.S. agencies and their Chinese counterparts. For instance, China Mobile Ltd, China Unicom, and China Telecom Corp announced their delisting from NYSE, citing investment restrictions dating from 2020.

Worth noting is that the delisting of firms was initiated due to strict measures put in place by the Trump administration. The current administration has left the regulations in place while proposing additional regulations. For instance, a recent regulation update by the Securities Exchange Commission requiring US-listed Chinese companies to disclose their ownership structure has led to the exit of cab-hailing company Didi from the NYSE.

Impact of pandemic on the listing of companies

The delisting also comes in the wake of the Covid-19 pandemic that resulted in economic turmoil. With the shutdown of the economy, most companies entered into bankruptcies as the stock market crashed to historical lows.

Lower stock prices translate to less wealth for businesses, pension funds, and individual investors, and listed companies could not get the much-needed funding for their normal operations.

At the same time, the focus on more companies going public over the last year can be highlighted by firms on the Nasdaq exchange. Worth noting is that in 2020, there was tremendous growth in special purpose acquisition companies (SPACs), mainly driven by the impact of the coronavirus pandemic. With the uncertainty of raising money through the traditional means, SPACs found a perfect role to inject more funds into capital-starving companies to go public.

From the data, foreign companies listing in the United States have grown steadily, with the business aiming to leverage the benefits of operating in the country. Notably, listing on U.S. exchanges guarantees companies liquidity and high potential to raise capital. Furthermore, listing on either NYSE or Nasdaq comes with the needed credibility to attract more investors. The companies are generally viewed as a home for established, respected, and successful global companies.

In general, over the past year, factors like the pandemic have altered the face of stock exchanges to some point threatening the continued dominance of major U.S. exchanges. Tensions between the US and China are contributing to the crisis which will eventually impact the number of listed companies.


Courtesy of Finbold.

Read More

Continue Reading